Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells.

PubWeight™: 2.25‹?› | Rank: Top 2%

🔗 View Article (PMC 2271008)

Published in J Exp Med on February 11, 2008

Authors

Benedetta Mazzinghi1, Elisa Ronconi, Elena Lazzeri, Costanza Sagrinati, Lara Ballerini, Maria Lucia Angelotti, Eliana Parente, Rosa Mancina, Giuseppe Stefano Netti, Francesca Becherucci, Mauro Gacci, Marco Carini, Loreto Gesualdo, Mario Rotondi, Enrico Maggi, Laura Lasagni, Mario Serio, Sergio Romagnani, Paola Romagnani

Author Affiliations

1: Excellence Center for Research, Transfer and High Education DENOthe, University of Florence, 50121 Florence, Italy.

Articles citing this

Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol (2008) 3.80

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev (2010) 3.24

Renal progenitors: an evolutionary conserved strategy for kidney regeneration. Nat Rev Nephrol (2013) 2.66

CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS One (2010) 2.28

Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Proc Natl Acad Sci U S A (2010) 2.00

Proliferation and migration of label-retaining cells of the kidney papilla. J Am Soc Nephrol (2009) 1.99

Microfluidic endothelium for studying the intravascular adhesion of metastatic breast cancer cells. PLoS One (2009) 1.87

CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration. J Biol Chem (2011) 1.78

Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells. J Exp Clin Cancer Res (2010) 1.59

The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury. PLoS One (2012) 1.56

Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis. J Am Soc Nephrol (2009) 1.54

De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease. Am J Physiol Renal Physiol (2009) 1.45

Imaging ligand-dependent activation of CXCR7. Neoplasia (2009) 1.43

The blood-brain barrier, chemokines and multiple sclerosis. Biochim Biophys Acta (2010) 1.40

Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells (2010) 1.38

Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells (2010) 1.36

Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis. Mol Cancer (2010) 1.36

The role of stromal-derived factor-1--CXCR7 axis in development and cancer. Eur J Pharmacol (2009) 1.30

Human nephrosclerosis triggers a hypoxia-related glomerulopathy. Am J Pathol (2009) 1.27

Toward the identification of a "renopoietic system"? Stem Cells (2009) 1.27

Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation. J Leukoc Biol (2008) 1.25

The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice. J Clin Invest (2012) 1.18

Immune regulation by atypical chemokine receptors. Nat Rev Immunol (2013) 1.17

Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells. PLoS One (2011) 1.16

Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev (2011) 1.12

Glomerular parietal epithelial cells of adult murine kidney undergo EMT to generate cells with traits of renal progenitors. J Cell Mol Med (2011) 1.08

Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory bowel disease. Theranostics (2013) 1.06

Functional diversity of SDF-1 splicing variants. Cell Adh Migr (2009) 1.03

Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma. PLoS One (2012) 0.98

CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment. Front Cell Neurosci (2014) 0.96

Multipotent stem cells in the Malpighian tubules of adult Drosophila melanogaster. J Exp Biol (2009) 0.96

CXCR7 protein expression in human adult brain and differentiated neurons. PLoS One (2011) 0.96

Targeting stem cell niches and trafficking for cardiovascular therapy. Pharmacol Ther (2010) 0.95

The use of lineage tracing to study kidney injury and regeneration. Nat Rev Nephrol (2015) 0.95

Possible mechanisms of kidney repair. Fibrogenesis Tissue Repair (2009) 0.95

Stromal cell-derived factor-1 and hematopoietic cell homing in an adult zebrafish model of hematopoietic cell transplantation. Blood (2011) 0.94

SDF-1α secreted by human CD133-derived multipotent stromal cells promotes neural progenitor cell survival through CXCR7. Stem Cells Dev (2010) 0.94

Differential expression of RDC1/CXCR7 in the human placenta. J Clin Immunol (2008) 0.93

CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells. Cell Death Dis (2014) 0.92

Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer. Mol Cancer (2014) 0.91

Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels. Immunology (2014) 0.90

Carboxy-terminus of CXCR7 regulates receptor localization and function. Int J Biochem Cell Biol (2012) 0.89

CXCR7 is induced by hypoxia and mediates glioma cell migration towards SDF-1α. BMC Cancer (2013) 0.89

Podocyturia: What is in a name? J Transl Int Med (2015) 0.88

Crosstalk between SDF-1/CXCR4 and SDF-1/CXCR7 in cardiac stem cell migration. Sci Rep (2015) 0.86

Renoprotective effects of hepatocyte growth factor in the stenotic kidney. Am J Physiol Renal Physiol (2012) 0.86

CXCR7-dependent angiogenic mononuclear cell trafficking regulates tumor progression in multiple myeloma. Blood (2014) 0.86

CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12. PLoS One (2014) 0.85

Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats. Br J Cancer (2014) 0.85

Family portrait: renal progenitor of Bowman's capsule and its tubular brothers. Am J Pathol (2011) 0.85

SDF-1 activates papillary label-retaining cells during kidney repair from injury. Am J Physiol Renal Physiol (2012) 0.84

Cytoplasmic trapping of CXCR4 in hepatocellular carcinoma cell lines. Cancer Res Treat (2008) 0.84

Improving outcomes of acute kidney injury using mouse renal progenitor cells alone or in combination with erythropoietin or suramin. Stem Cell Res Ther (2013) 0.84

Renal progenitors and childhood: from development to disorders. Pediatr Nephrol (2014) 0.83

CXCR4 but not CXCR7 is mainly implicated in ocular leukocyte trafficking during ovalbumin-induced acute uveitis. Exp Eye Res (2009) 0.83

Mesenchymal stem cells utilize CXCR4-SDF-1 signaling for acute, but not chronic, trafficking to gastric mucosal inflammation. Dig Dis Sci (2013) 0.82

Targeting aldehyde dehydrogenase: a potential approach for cell labeling. Nucl Med Biol (2009) 0.81

Administration of BMSCs with muscone in rats with gentamicin-induced AKI improves their therapeutic efficacy. PLoS One (2014) 0.81

Role of SDF-1 as a regulatory chemokine in renal regeneration after acute kidney injury. Kidney Int Suppl (2011) (2011) 0.81

Chemokine receptor CXCR7 is a functional receptor for CXCL12 in brain endothelial cells. PLoS One (2014) 0.80

Mobilization of circulating endothelial progenitor cells correlates with the clinical course of hantavirus disease. J Virol (2013) 0.80

Mechanisms and consequences of injury and repair in older organ transplants. Transplantation (2014) 0.80

Claudin 1 and nephrin label cellular crescents in diabetic glomerulosclerosis. Hum Pathol (2013) 0.80

SDF-1/CXCR4 signaling preserves microvascular integrity and renal function in chronic kidney disease. PLoS One (2014) 0.80

Complement inhibition decreases early fibrogenic events in the lung of septic baboons. J Cell Mol Med (2015) 0.79

Profiling of Cxcl12 receptors, Cxcr4 and Cxcr7 in murine testis development and a spermatogenic depletion model indicates a role for Cxcr7 in controlling Cxcl12 activity. PLoS One (2014) 0.77

New insights into glomerular parietal epithelial cell activation and its signaling pathways in glomerular diseases. Biomed Res Int (2015) 0.77

Role of medullary progenitor cells in epithelial cell migration and proliferation. Am J Physiol Renal Physiol (2014) 0.76

Differential Expression of Chemokine Receptors and their Roles in Cancer Imaging. Front Oncol (2012) 0.76

The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing. PLoS One (2015) 0.75

Chemokines and Chemokine Receptors in the Development of Lupus Nephritis. Mediators Inflamm (2016) 0.75

C-X-C motif receptor 7 in gastrointestinal cancer. Oncol Lett (2015) 0.75

Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy. Stem Cells Int (2016) 0.75

SDF-1/CXCR7 axis regulates the proliferation, invasion, adhesion, and angiogenesis of gastric cancer cells. World J Surg Oncol (2016) 0.75

A previously unrecognized role of C3a in proteinuric progressive nephropathy. Sci Rep (2016) 0.75

SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease. PLoS One (2016) 0.75

Chemically primed bone-marrow derived mesenchymal stem cells show enhanced expression of chemokine receptors contributed to their migration capability. Iran J Basic Med Sci (2016) 0.75

Expression and functional roles of the chemokine receptor CXCR7 in acute myeloid leukemia cells. Blood Res (2015) 0.75

Progenitor-like cells derived from mouse kidney protect against renal fibrosis in a remnant kidney model via decreased endothelial mesenchymal transition. Stem Cell Res Ther (2015) 0.75

Effects of linagliptin on human immortalized podocytes: a cellular system to study dipeptidyl-peptidase 4 inhibition. Br J Pharmacol (2017) 0.75

CXCR7/p-ERK-Signaling Is a Novel Target for Therapeutic Vasculogenesis in Patients with Coronary Artery Disease. PLoS One (2016) 0.75

Articles cited by this

Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem (1980) 28.03

Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science (1999) 8.43

A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med (2006) 6.86

Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med (2006) 5.33

How do stem cells find their way home? Blood (2005) 5.13

The evolving concept of a stem cell: entity or function? Cell (2001) 4.26

Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol (2007) 4.17

Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest (2005) 4.10

Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol (2006) 3.95

Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol (2004) 3.41

The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood (2000) 3.30

Isolation of renal progenitor cells from adult human kidney. Am J Pathol (2005) 3.12

The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia (2006) 3.08

Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc Natl Acad Sci U S A (2006) 3.03

The renal papilla is a niche for adult kidney stem cells. J Clin Invest (2004) 3.03

Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest (2005) 2.94

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med (2003) 2.91

Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest (2003) 2.81

The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood (1998) 2.78

CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res (2005) 2.62

Identification of renal progenitor-like tubular cells that participate in the regeneration processes of the kidney. J Am Soc Nephrol (2003) 2.44

Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int (2005) 2.29

Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol (2006) 2.24

Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood (2005) 2.13

Isolation and characterization of kidney-derived stem cells. J Am Soc Nephrol (2006) 2.05

Angiotensin II-induced reactive oxygen species and the kidney. J Am Soc Nephrol (2007) 1.92

Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells (2006) 1.90

Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol (2005) 1.90

Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol (2007) 1.87

Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest (2001) 1.84

CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol (2004) 1.77

Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo. J Immunol (2003) 1.75

Kidney side population reveals multilineage potential and renal functional capacity but also cellular heterogeneity. J Am Soc Nephrol (2006) 1.70

Isolation and characterization of nontubular sca-1+lin- multipotent stem/progenitor cells from adult mouse kidney. J Am Soc Nephrol (2006) 1.59

Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J Cell Biol (2006) 1.40

Regrow or repair: potential regenerative therapies for the kidney. J Am Soc Nephrol (2006) 1.37

The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovasc Revasc Med (2006) 1.35

Total body irradiation causes profound changes in endothelial traffic molecules for hematopoietic progenitor cell recruitment to bone marrow. Blood (2002) 1.23

Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution. J Am Soc Nephrol (2005) 1.23

Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications. J Clin Invest (1992) 1.22

Mobilization of hematopoietic stem cells. Blood Rev (2000) 1.03

Lack of a functional p21WAF1/CIP1 gene accelerates caspase-independent apoptosis induced by cisplatin in renal cells. Am J Physiol Renal Physiol (2003) 1.00

Involvement of peripheral benzodiazepine receptor in the oxidative stress, death-signaling pathways, and renal injury induced by ischemia-reperfusion. J Am Soc Nephrol (2004) 0.96

Pharmacological modulation of stem cell function. Curr Med Chem (2007) 0.93

Peripheral blood as a source of stem cells for regenerative medicine. Expert Opin Biol Ther (2006) 0.83

Articles by these authors

Phenotypic and functional features of human Th17 cells. J Exp Med (2007) 11.33

Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med (2005) 7.83

Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med (2008) 4.30

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells (2005) 4.26

Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol (2006) 3.95

Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol (2008) 3.80

Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J Exp Med (2002) 3.47

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int (2014) 3.40

Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet (2011) 3.15

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med (2003) 2.91

Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol (2010) 2.82

Evidence for a cross-talk between human neutrophils and Th17 cells. Blood (2009) 2.75

Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol (2009) 2.70

Renal progenitors: an evolutionary conserved strategy for kidney regeneration. Nat Rev Nephrol (2013) 2.66

CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res (2005) 2.62

Regenerative potential of embryonic renal multipotent progenitors in acute renal failure. J Am Soc Nephrol (2007) 2.42

MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition. J Am Soc Nephrol (2012) 2.26

Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum (2011) 2.24

Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol (2005) 2.18

Histopathologic analysis of peritumoral pseudocapsule and surgical margin status after tumor enucleation for renal cell carcinoma. Eur Urol (2008) 2.17

Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells (2007) 2.12

A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol (2012) 2.11

Proteinuria impairs podocyte regeneration by sequestering retinoic acid. J Am Soc Nephrol (2013) 2.09

Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI. Int J Cardiol (2007) 2.05

CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur J Immunol (2010) 2.03

Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol (2010) 2.02

Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. J Exp Med (2002) 1.95

Type 17 T helper cells-origins, features and possible roles in rheumatic disease. Nat Rev Rheumatol (2009) 1.90

Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to Plasmodium falciparum malaria. Proc Natl Acad Sci U S A (2008) 1.86

Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood (2003) 1.79